Abstract:Aflatoxin B1 (AFB1) accumulates in crops, where it poses a threat to human health. To detect AFB1, anti-AFB1 monoclonal antibodies have been developed and are widely used. While the sensitivity and specificity of these antibodies have been extensively studied, information regarding the atomic-level docking of AFB1 (and its derivatives) with these antibodies is limited. Such information is crucial for understanding the key interactions that are required for high affinity and specificity in aflatoxin binding. First, a 3D comparative model of anti-AFB1 antibody (Ab-4B5G6) was predicted from the sequence using RosettaAntibody. We then utilized RosettaLigand to dock AFB1 onto ten homology models, producing a total of 10,000 binding modes. Interestingly, the best-scoring mode predicted strong interactions involving four sites within the heavy chain: ALA33, ASN52, HIS95, and TRP99. Importantly, these strong binding interactions exclusively involve the variable domain of the heavy chain. The best-scoring mode with AFB1 was also obtained through AF multimer combined with RosettaLigand, and two interactions at TRP and HIS were consistent with those found by Rosetta antibody-ligand computational simulation. The role of tryptophan in π interactions in antibodies was confirmed through mutation experiments, and the resulting mutant (W99A) exhibited a >1000-fold reduction in binding affinity for AFB1 and analogs, indicating the effect of tryptophan on the stability of CDR-H3 region. Additionally, we evaluated the binding of two glycolic acid-derived molecular derivatives (with impaired hydrogen bonding potential), and these derivatives (AFB2-GA and AFG2-GA) demonstrated a very weak binding affinity for Ab-4B5G6. The heavy chain was successfully isolated, and its sensitivity and specificity were consistent with those of the intact antibody. The homology models of variable heavy (VH) single-domain antibodies were established by RosettaAntibody, and the docking analysis revealed the same residues, including Ala, His, and Trp. Compared to the potential binding mode of fragment variable (FV) region, the results from a model of VH indicated that there are seven models involved in hydrophobic interaction with TYR32, which is usually referred to as polar amino acid and has both hydrophobic and hydrophilic features depending on the circumstances. Our work encompasses the entire process of Rosetta antibody-ligand computational simulation, highlighting the significance of variable heavy domain structural design in enhancing molecular interactions.

Development of Aflatoxin B(1)-lysine Adduct Monoclonal Antibody for Human Exposure Studies.

Development of Aflatoxin B <sub>1</sub> -Lysine Adduct Monoclonal Antibody for Human Exposure Studies

Development Studies of Aflatoxin B2a

Synthesis and Identification of Aflatoxin B2a Artificial Antigens: the First Critical Step in Preparing Monoclonal Antibodies Against Aflatoxin B1

Preparation of AflatoxinB1 Complete Antigen and Mouse Polyclonal Antiserum

Development of monoclonal antibody against Aflatoxin M1 and the establishment of quantitative ELISA

Chemical and physical properties of the major serum albumin adduct of aflatoxin B1 and their implications for the quantification in biological samples

Quantitation Of Aflatoxin B1-Dna Adducts In Woodchuck Hepatocytes And Rat-Liver Tissue By Indirect Immunofluorescence Analysis

A Non-Toxic Enzyme-Linked Immunosorbent Assay for Aflatoxin B1 Using Anti-Idiotypic Antibodies As Substitutes.

Preparation of aflatoxin B1 polyclonal antibody and development of an indirect competitive enzyme-linked immunosorbent assay

Development of a New Broad-Specific Monoclonal Antibody with Uniform Affinity for Aflatoxins and Magnetic Beads-Based Enzymatic Immunoassay

Production of ultrasensitive generic monoclonal antibodies against major aflatoxins using a modified two-step screening procedure.

Spectral Characteristics of Fluorescence and Circular Dichroism of Aflatoxin B1 Reaction with Its Anti-Idiotypic Antibody

[Detection of Aflatoxin-Albumin Adducts in Human Serum and Its Application].

Isolation and Characterization of Recombinant Variable Domain of Heavy Chain Anti-Idiotypic Antibodies Specific to Aflatoxin B1.

Establishment of Immunologic Detection Method for Aflatoxin B1 Based on Preparation of Aflatoxin B1 Monoclonal Antibody

Mass Spectrometry-Based Method to Measure Aflatoxin B 1 DNA Adducts in Formalin-Fixed Paraffin-Embedded Tissues

Characterization of a Novel Monoclonal Antibody with High Affinity and Specificity against Aflatoxins: A Discovery from Rosetta Antibody-Ligand Computational Simulation

Immunohistochemical Detection of Aflatoxin B1-DNA Adducts and Hepatitis B Virus Antigens in Hepatocellular Carcinoma and Nontumorous Liver Tissue.

Development and Validation of a Sensitive Monoclonal Antibody-Based Ic-Elisa for the Aflatoxin M1 in Milk (Abstract)

Development and validation of a sensitive monoclonal antibody-based indirect competitive enzyme-linked immunosorbent assay for the determination of the aflatoxin M1 levels in milk.